158 related articles for article (PubMed ID: 9531049)
1. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
Hantgan RR; Jerome WG; Handt S
Thromb Haemost; 1998 Mar; 79(3):602-8. PubMed ID: 9531049
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
Braaten JV; Jerome WG; Hantgan RR
Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor-resistant tissue-type plasminogen activator: an improved thrombolytic agent in vitro.
Shohet RV; Spitzer S; Madison EL; Bassel-Duby R; Gething MJ; Sambrook JF
Thromb Haemost; 1994 Jan; 71(1):124-8. PubMed ID: 8165630
[TBL] [Abstract][Full Text] [Related]
5. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
6. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
Flight SM; Masci PP; Lavin MF; Gaffney PJ
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
[TBL] [Abstract][Full Text] [Related]
7. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
[TBL] [Abstract][Full Text] [Related]
8. [Plasminogen activator of tissue type. Physiology, pathophysiology and clinical value].
Korninger C
Wien Klin Wochenschr; 1985 Nov; 97(22):832-40. PubMed ID: 2934899
[TBL] [Abstract][Full Text] [Related]
9. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T
Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447
[TBL] [Abstract][Full Text] [Related]
10. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
11. The effect of flow on lysis of plasma clots in a plasma environment.
Sakharov DV; Rijken DC
Thromb Haemost; 2000 Mar; 83(3):469-74. PubMed ID: 10744155
[TBL] [Abstract][Full Text] [Related]
12. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
13. Perturbation of platelet adhesion to endothelial cells by plasminogen activation in vitro.
Chen H; Wu YI; Hsieh YL; Shi GY; Jiang MJ; Chang WC; Chuang WJ; Kan WM; Tang MJ; Jen CJ
Thromb Haemost; 1997 Aug; 78(2):934-8. PubMed ID: 9268198
[TBL] [Abstract][Full Text] [Related]
14. Görög Thrombosis Test: a global in-vitro test of platelet function and thrombolysis.
Yamamoto J; Yamashita T; Ikarugi H; Taka T; Hashimoto M; Ishii H; Watanabe S; Kovacs IB
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):31-9. PubMed ID: 12544726
[TBL] [Abstract][Full Text] [Related]
15. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
[TBL] [Abstract][Full Text] [Related]
16. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
[TBL] [Abstract][Full Text] [Related]
17. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
Wootton DM; Popel AS; Alevriadou BR
Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
[TBL] [Abstract][Full Text] [Related]
18. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
Stringer HA; van Swieten P; Heijnen HF; Sixma JJ; Pannekoek H
Arterioscler Thromb; 1994 Sep; 14(9):1452-8. PubMed ID: 8068607
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells organize fibrin clots into structures that are more resistant to lysis.
Jerome WG; Handt S; Hantgan RR
Microsc Microanal; 2005 Jun; 11(3):268-77. PubMed ID: 16060980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]